Insurers push back against growing cost of cancer treatments
Some cancer patients and their insurers are seeing their bills for chemotherapy jump sharply, reflecting increased drug prices and hospitals' push to buy oncologists' practices and then bill at higher rates. Patients say, "'I've been treated with Herceptin for breast cancer for several years and it was always $5,000 for the drug and suddenly it's $16,000 -- and I was in the same room with the same doctor same nurse and the same length of time'," said Dr. Donald Fischer, chief medical officer for Highmark, the largest health plan in Pennsylvania.
- Governors Push to Expand Role of PAs, Telemedicine
- 3 More Pioneer ACOs Say They Will Quit
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- Top Provider Billing Mistakes Are Changing
- Payer Calls for More Primary Care Docs, Team Care
- Why Open Payments Irks Physicians
- Employee Engagement: Make It Meaningful
- These Algorithms Reduce Readmissions
- Overcoming a Payer Mix 'Nightmare'
- Open Payments Site Launches to User Complaints